StonvexLoading…
StonvexStonvexStonvexCore line items from OBIO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $110.00K | $33.48M | $2.56M | $1.70M |
Operating Income | $-22.08M | $-51.81M | $-58.56M | $-38.25M |
Net Income | $-20.69M | $-52.70M | $-58.95M | $-19.36M |
EPS (Diluted) | $-0.33 | $-1.11 | $-1.37 | $-0.99 |
Total Assets | $100.66M | $114.86M | $104.81M | $42.83M |
Total Liabilities | $49.69M | $51.48M | $61.07M | $42.53M |
Cash & Equivalents | $28.37M | $34.69M | $42.01M | $18.75M |
Free Cash Flow OCF − CapEx | $-22.35M | $-49.45M | $-47.15M | $-32.29M |
Shares Outstanding | 58.63M | 57.03M | 56.46M | 38.64M |